GSKs

Exton, Pennsylvania, July 20, 2023 (GLOBE NEWSWIRE) -- Nephrologists have long awaited the approval of HIF-PH inhibitors for the treatment of anemia in their chronic kidney disease (CKD)…

A GSK lab in London.Oli Scarff | Getty ImagesThe Food and Drug Administration on Wednesday approved an RSV vaccine produced by GlaxoSmithKline for use on adults ages 60 and older.The…

The Food and Drug Administration's independent panel of advisors on Wednesday recommended GlaxoSmithKline's RSV vaccine for adults ages 60 and older, though they flagged potential safety…

Data show overall vaccine efficacy of 82.6% against RSV-lower respiratory tract disease (LRTD) in adults aged 60 years and above, with consistent high vaccine efficacy observed in severe…

First RSV vaccine candidate to show statistically significant and clinically meaningful efficacy in adults aged 60 years and aboveThird AS01 adjuvanted vaccine containing QS-21 STIMULON to…

WASHINGTON (AP) — GlaxoSmithKline’s IV drug for COVID-19 should no longer be used because it is likely ineffective against the omicron subvariant that now accounts for most…

Unilever’s bid did not include any takeover premium or recognition of synergies, the newspaper said, adding that it was not clear whether the group would make a higher offer. Consumer goods…

Consumer goods giant said it had approached about buying the pharmaceutical group's consumer goods arm, after a newspaper reported that a 50 billion-pound ($68.4 billion) bid it made had…

© Reuters. FILE PHOTO: General view outside GlaxoSmithKline (GSK) headquarters in Brentford, London, Britain, May 4, 2020. REUTERS/Matthew Childs LONDON (Reuters) -Consumer goods giant…

Unilever has approached GlaxoSmithKline about a potential acquisition of its consumer health joint venture with Pfizer for as much as £50bn in what could become one of the London…